Hummingbird Bioscience reels in $19 mln Series B
Hummingbird Bioscience, a biotherapeutics company, has raised $19 million in Series B financing.
Hummingbird Bioscience, a biotherapeutics company, has raised $19 million in Series B financing.
Copyright PEI Media
Not for publication, email or dissemination